| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | E524N2IXA3 |
| InChI Key | AHLPHDHHMVZTML-BYPYZUCNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C5H12N2O2 |
| Molecular Weight | 132.16 |
| AlogP | -0.86 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 89.34 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 9.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Brain Diseases | 3 | D001927 | ClinicalTrials |
| Liver Failure, Acute | 2 | D017114 | ClinicalTrials |
| Medulloblastoma | 2 | D008527 | ClinicalTrials |
| Skin Neoplasms | 2 | D012878 | ClinicalTrials |
| Neuroblastoma | 2 | D009447 | ClinicalTrials |
| Propionic Acidemia | 1 | D056693 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 1 | D003922 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 15729 |
| ChEMBL | CHEMBL446143 |
| DrugBank | DB00129 |
| DrugCentral | 3401 |
| EPA CompTox | DTXSID00883219 |
| FDA SRS | E524N2IXA3 |
| Human Metabolome Database | HMDB0000214 |
| Guide to Pharmacology | 725 |
| KEGG | C00077 |
| PDB | ORN |
| PharmGKB | PA164783814 |
| PubChem | 6262 |
| SureChEMBL | SCHEMBL8579 |
| ZINC | ZINC000001532530 |